Centeon Humate-P supply will cover demand until firm resumes production in Marburg, Germany.
Executive Summary
CENTEON HUMATE-P MANUFACTURING RESUMPTION WILL NOT BE DELAYED BY GMP ISSUES cited in a Dec. 8 FDA warning letter regarding the company's Marburg, Germany facility, the company maintained Jan. 7. Centeon expects to integrate changes required in response to the warning letter into its existing timeframe for restarting production in several months. The line has been shut down since May 1997 for extensive renovations including installation and validation of new equipment.